Answers are grounded in this paper and cite their sources.
Levofloxacin is an antituberculosis drug with substantial interindividual pharmacokinetic variability; therapeutic drug monitoring (TDM) could therefore be helpful to improve treatment results. TDM would be more feasible with limited sampling strategies (LSSs), a method to estimate the area under the concentration curve for the 24-h dosing interval (AUC 0–24 ) by using a limited number of samples.
No takes yet. Share an insight, caveat, or question.
Elsen et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: